论文部分内容阅读
目的探讨多巴胺对肺炎合并心力衰竭患儿的治疗效果。方法选取2015年6月至2016年6月我院收治的150例肺炎合并心力衰竭患儿作为本次研究对象。依照就诊时间差异将150例患儿随机分为对照组和观察组进行探讨,每组各有75例,对照组患儿给予强心、抗感染、止咳平喘等常规治疗。观察组患儿在常规治疗的基础上增加使用多巴胺治疗,对比两组患儿的治疗效果。结果观察组患儿治疗效果显著优于对照组,且治疗期间未出现严重不良反应,两组数据比较差异有统计学意义(P<0.05)。结论肺炎合并心力衰竭患儿在常规治疗的基础上增加使用多巴胺治疗效果显著,不良反应率低,具有较高的安全性。
Objective To investigate the therapeutic effect of dopamine on children with pneumonia complicated with heart failure. Methods From June 2015 to June 2016, 150 children with pneumonia complicated with heart failure admitted to our hospital were selected as the study objects. 150 cases were randomly divided into control group and observation group according to the time difference of treatment. Each group had 75 cases. The control group received routine therapy such as cardiotonic, anti-infective, cough and asthma. Children in the observation group were given dopamine treatment on the basis of routine treatment, and compared the therapeutic effect of the two groups of children. Results The therapeutic effect of the observation group was significantly better than that of the control group, and no serious side effects occurred during the treatment. There was significant difference between the two groups (P <0.05). Conclusions Children with pneumonia complicated with heart failure have more effective treatment with dopamine on the basis of routine treatment, with low adverse reaction rate and high safety.